EX-99.1 2 ea026643301ex99-1_bespoke.htm PRESS RELEASE, DATED NOVEMBER 12, 2025

Exhibit 99.1

 

 

 

Bespoke Extracts, Inc. Reports Third Quarter 2025 Results – The Joint Company Scales Colorado Production and Margin Leadership

 

AURORA, Colo., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (OTCQB: BSPK), operating as The Joint Company, today announced record results for the quarter ended September 30, 2025 — marking its strongest operational and financial performance to date.

 

“We’re not chasing the market — we’re building it,” said Hunter Garth, President of Bespoke Extracts. “Our Colorado business continues to prove that disciplined execution, brand trust, and smart manufacturing can win even in a contracting cannabis market. Q3 was a turning point. We produced more pre-rolls, earned strong margins, and expanded our reach — all while holding the line on overhead costs.”

 

Third Quarter 2025 Highlights

 

·Record Revenue: $467,945, up 19.8% from Q2 2025 and 68.6% year-over-year.
   
·Gross Margin: 50.0%, up 860 basis points versus the prior year, driven by material, labor, and packaging efficiencies.
   
·Net Loss Improvement: GAAP net loss narrowed to $78,088, a 72% improvement from Q3 2024.
   
·Record Production: 209,600 pre-rolls produced during the quarter — up 81% year-over-year.

 

Management Commentary

 

“Our 2025 strategic plan is delivering results, with demonstrable progress on revenue growth, distribution, and branded products,” said Michael Feinsod, Bespoke Chairman and CEO. “Our flexibility to adapt to changing market conditions in our core pre-roll business has allowed us to succeed this year in Colorado, setting us apart from many other participants.”

 

“We’ve built each of our brands brick by brick in one of the toughest cannabis markets in the country,” said Garth. “The fact that we can grow revenue by approximately 69% while expanding margins in a shrinking market says everything about our team and our process.

 

“This is what operational excellence looks like — continual improvement through iteration, data, and pride in the craft.”

 

“These Q3 results are a testament to the resilience and innovation at the core of The Joint Company,” said Michael Feinsod. “Our team's focus on efficiency and quality has not only driven record growth but also positioned us for scalable expansion. We're excited about the pipeline ahead and confident in delivering sustained value to shareholders.” 

 

 

 

 

Financial Highlights

 

Results of Operations  For the Three Months Ended   For the Nine Months Ended 
   September
30, 2025		   September
30, 2024		   % Change   June
30, 2025		   % Change   September
30, 2025		   September
30, 2024		   % Change 
Revenue  $467,945   $277,471    68.6%  $390,553    19.8%  $1,121,657   $816,062    37.4%
Gross Profit  $234,175   $114,995    103.6%  $197,499    18.6%  $542,453   $323,693    67.6%
Gross Margin   50.0%   41.4%        50.6%        48.4%   39.7%     
Operating Expenses  $288,066   $377,463    -23.7%  $359,457    -19.9%  $1,003,640   $1,139,207    -11.9%
                                         
Net loss  $(78,088)  $(275,613)   -71.7%  $(205,106)   -61.9%  $(543,715)  $(850,626)   -36.1%
Basic and diluted shares outstanding   11,249,959    10,635,068         11,153,220         11,185,821    10,327,972      
EPS  $(0.01)  $(0.03)       $(0.02)       $(0.05)  $(0.08)     

 

Building from the Ground Up

 

Fourth Quarter 2025 Outlook

 

·Revenue: Projected between $425,000 and $500,000, up 41%–66% year-over-year, driven by continued demand for Fresh Joints and expansion of Doobskis and Dutch Blunts.
   
·Gross Margin: The company expects to maintain approximately 50% blended gross margins across product lines through disciplined cost management and increased production throughput.
   
·Innovation: Two new Company owned brands are set to launch in Q4, designed to capture adjacent market segments with highly competitive price-to-quality positioning.
   
·Expansion: Bespoke continues to evaluate opportunities to replicate The Joint Company model in additional regulated markets, including Massachusetts and New York.
   
·The company’s core brand, Fresh Joints, continues to lead Colorado’s pre-roll category in quality and volume growth. Meanwhile, new launches, Doobskis and Dutch Blunts gained meaningful traction with retail partners, creating diversified revenue streams and establishing The Joint Company as a multi-brand pre-roll house.

 

“We’re turning a single-state success story into a scalable blueprint,” Garth added. “Our aim is simple — to control the pre-roll category through quality, efficiency, and culture. What started as a manufacturing facility in Aurora is now a system that can be replicated across markets.”

 

2 
 

  

Bespoke Extracts, Inc.

Consolidated Balance Sheets

(Unaudited)

 

    

September

30,

    

December 

 31,

 
    2025    2024 
           
Assets          
Current assets          
Cash  $16,743   $60,305 
Accounts receivable, net   103,532    57,276 
Prepaid expense   12,895    15,150 
Inventory, net   63,662    32,526 
Total current assets   196,832    165,257 
           
Furniture and equipment   24,051    31,342 
License   10,000    10,000 
Right of Use Asset   52,690    140,489 
Deposits   12,000    12,000 
Total assets  $295,573   $359,088 
           
Liabilities and Stockholders' Equity          
Current liabilities          
Accounts payable and accrued liabilities  $1,392,869   $958,276 
Note payable   25,000    20,000 
Advances - related party   66,872    66,872 
Operating lease liability   52,650    73,523 
Notes payable -- secured (Net of discount of $49,810)   335,190    - 
Total current liabilities   1,872,581    1,118,671 
           
Long-Term liabilities          
Notes payable -- secured (Net of discount of $68,649)   -    241,351 
Notes payable   169,000    169,000 
Note payable - related party   849,500    849,500 
Long-Term Operating Lease Liability   -    72,504 
Total liabilities   2,891,081    2,451,026 
           
Commitments and contingencies (Note 10)          
           
Stockholders' Deficit          
Preferred stock, par value $0.001, 50,000,000 shares authorized, 1 share issued and outstanding as of September 30, 2025 and December 31,2024, respectively   -    - 
Series C Convertible Preferred Stock, $0.001 par value, 1 share designated; 1 share issued and outstanding as of September 30, 2025 and  December 31, 2024, respectively, stated value $24,000.   -    - 
Common stock, $0.001 par value: 3,000,000,000 authorized; 11,253,220 and 11,153,220 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively   11,251    11,151 
Common stock to issue 6,478 shares   -    - 
Additional paid-in capital   24,341,072    24,301,027 
Accumulated deficit   (26,947,831)   (26,404,116)
Total stockholders' deficit   (2,595,508)   (2,091,938)
Total liabilities and stockholders' deficit  $295,573   $359,088 

 

See the notes to the condensed consolidated financial statements included in the Company’s 10Q filing.

 

3 
 

 

Bespoke Extracts, Inc.

Consolidated Statements of Operations

(Unaudited)

 

  

For the three months ended

September 30,

  

For the Nine Months  Ended

September 30,

 
   2025   2024   2025   2024 
                 
Sales  $467,945   $277,471   $1,121,657   $816,062 
Cost of products sold   233,770    162,476    579,204    492,369 
Gross Profit   234,175    114,995    542,453    323,693 
                     
Operating expenses:                    
Selling, general and administrative expenses   260,228    361,393    911,006    1,035,137 
Professional fees   27,838    16,070    92,634    104,070 
Total operating expenses   288,066    377,463    1,003,640    1,139,207 
                     
Loss from operations   (53,891)   (262,468)   (461,187)   (815,514)
                     
Other income / (expenses)                    
Interest expense   (24,197)   (13,145)   (82,528)   (35,112)
Total other (expense) / income   (24,197)   (13,145)   (82,528)   (35,112)
                     
Loss before income tax   (78,088)   (275,613)   (543,715)   (850,626)
Provision for income tax   -    -    -    - 
Net Loss  $(78,088)  $(275,613)  $(543,715)  $(850,626)
                     
                     
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING                    
Basic and Diluted   11,249,959    10,635,068    11,185,821    10,327,972 
                     
NET LOSS PER COMMON SHARE OUTSTANDING                    
Basic and Diluted  $(0.01)  $(0.03)  $(0.05)  $(0.08)

 

See the notes to the condensed consolidated financial statements included in the Company’s 10Q filing.

 

4 
 

 

About Bespoke Extracts, Inc.

 

Bespoke Extracts, Inc. (OTCQB: BSPK) is a Nevada corporation operating through its wholly-owned subsidiary, Bespoke Extracts Colorado, LLC. The company develops and manufactures branded and white-label cannabis products for the regulated U.S. market. Its flagship platform, The Joint Company, produces pre-rolls and infused products distributed across licensed Colorado dispensaries. The company currently manufactures under its owned brands FreshJoints, Doobskis, DutchBlunts and Sweet Joints.

 

For more information, visit: www.bespokeextracts.com

Email: [email protected]

 

Forward-Looking Statement

 

This release contains forward-looking statements subject to risks and uncertainties. Actual results may differ materially from those expressed due to market conditions, regulatory changes, and other risks described in Bespoke’s filings with the SEC. The company undertakes no obligation to update forward-looking statements, except as required by law.

 

 

5